FdaApplication
NDA 020250
Identifiers
- fda_app_no: NDA020250
Properties
| Property | Value |
|---|---|
| applicant_name | GLAXOSMITHKLINE |
| application_type | NDA |
| approval_date | 1992-07-24 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| HALFAN | HALOFANTRINE HYDROCHLORIDE | 250MG | TABLET;ORAL |
1 product